Microbiotica
Latest round
- Series C
Last raised
- Oct 2026
Total raised
- $121M
Investors
- 9
About Microbiotica
Founded in 2016 and headquartered in Cambridge, UK, Microbiotica Limited specializes in live biotherapeutics targeting various health conditions.18 million on March 4, 2022.Microbiotica specializes in the development of clinic-ready live biotherapeutic products (LBPs) that are orally delivered and composed of highly-defined bacterial strains. These products are specifically designed for therapeutic applications in immuno-oncology and inflammatory bowel disease. The company aims to translate advanced microbiome science into transformative medicines that address unmet medical needs, with a focus on improving patient outcomes. Microbiotica’s offerings are primarily targeted at healthcare providers and research institutions, which utilize these therapies to treat patients suffering from conditions such as ulcerative colitis and other related disorders.Microbiotica’s revenue model is centered around partnerships with healthcare providers and research institutions, where products are typically supplied through direct sales and clinical collaborations. The company conducts transactions that involve bulk orders of its biotherapeutic products to hospitals and clinics, facilitating access to advanced treatments for patients. Furthermore, Microbiotica engages in strategic partnerships with other biopharmaceutical firms to co-develop or co-market specific products, enhancing its market reach and revenue potential. Microbiotica plans to innovate new products and possibly explore expansion into new geographic regions, although specific markets have not been disclosed.
Who invested in Microbiotica
9 investors across 3 rounds
See all investors in Microbiotica
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Microbiotica
Who invested in Microbiotica?
Microbiotica has 9 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Microbiotica raised?
Microbiotica has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Microbiotica last raise money?
Microbiotica's most recent round on record is a Series C, in Oct 2026.
What does Microbiotica do?
Founded in 2016 and headquartered in Cambridge, UK, Microbiotica Limited specializes in live biotherapeutics targeting various health conditions.
Where is Microbiotica headquartered?
Microbiotica is headquartered in Cambridge, UK.
Which VCs invest in companies like Microbiotica?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at Microbiotica's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Microbiotica? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.